Bioavailability of rectal acetaminophen in children following anorectal surgery

Reza Shojaeian1, Anahita Alizadeh Ghamsari1, Ahmad Mohammadipour2

  • 1Mashhad University of Medical Sciences, Iran.

Insights

Rectal acetaminophen bioavailability may change in children after anorectal surgery. Caution is advised with rectal acetaminophen in infants with a history of anorectal operations due to potential toxic levels.

Area of Science:

  • Pediatric Surgery
  • Pharmacokinetics
  • Anorectal Surgery

Background:

  • Rectal acetaminophen is commonly used in pediatrics.
  • Anorectal surgery can alter drug pharmacokinetics.
  • The impact on rectal acetaminophen bioavailability is not well understood.

Purpose of the Study:

  • To investigate acetaminophen plasma concentrations in children post-anorectal surgery.
  • To determine the absorption, safety, and efficacy of rectal acetaminophen in this population.

Main Methods:

  • Prospective comparative study involving 60 children.
  • Groups included Hirschsprung's disease (HD), imperforate anus (IA) repair, and inguinal herniotomy.
  • Blood samples were collected 4, 8, and 12 hours after a single rectal dose (40 mg/kg).

Main Results:

  • Children with HD showed significantly higher acetaminophen levels than the herniotomy group (P < 0.05).
  • IA group had higher concentrations than the herniotomy group, but not statistically significant.
  • Acetaminophen levels in IA and HD groups exceeded the therapeutic range at 4 hours.

Conclusions:

  • Rectal acetaminophen bioavailability may be altered following major anorectal surgery in children.
  • Administer rectal acetaminophen with caution in children with a history of anorectal operations.
  • Repeated doses could lead to toxic drug concentrations in these patients.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
148
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
113
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
176
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
113
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
374